Non-Injectable Option
The oral-tablet format may appeal to eligible patients who prefer not to use an injectable treatment.

WEIGHT MANAGEMENT
ORAL TABLETS
A provider-guided oral treatment option for eligible adults pursuing meaningful, sustainable weight-management goals.
Tirzepatide acts on GIP and GLP-1 receptor pathways involved in appetite, fullness, food intake, digestion, and blood-sugar regulation. This compounded oral-tablet format may provide a non-injectable option when a licensed provider determines that it is medically appropriate for an individual patient.
Individual results vary. Treatment requires medical evaluation and is not appropriate for everyone.
$350/month
All-inclusive pricing
The prescribing provider and dispensing pharmacy determine the formulation, strength, dose, administration instructions, and fulfillment schedule.
Prescription treatment requires an online medical evaluation. A licensed provider determines whether treatment is clinically appropriate. Treatment is not guaranteed.
Tirzepatide acts on glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1, receptor pathways. These pathways are involved in appetite, fullness, food intake, digestion, and blood-sugar regulation.
The oral-tablet format may appeal to eligible patients who prefer not to use an injectable treatment.
Tirzepatide acts on pathways involved in appetite and fullness. Individual experiences vary.
When medically appropriate, treatment may be used alongside nutrition, physical activity, and ongoing clinical care.
A licensed provider reviews eligibility and determines the individualized prescription and administration instructions.
Potential benefits are not guaranteed. Results and treatment duration vary.
How it works
Simple online care, reviewed by licensed medical providers.
Complete a secure online health assessment so your provider can understand your goals, symptoms, and medical history.

A licensed medical provider evaluates your information and determines which treatment options may be clinically appropriate.

If prescribed, your treatment is delivered discreetly, with ongoing support and follow-up as needed.

Tirzepatide Oral Tablets may be considered for certain adults seeking provider-guided medical support for weight management and who may prefer a non-injectable format. Eligibility depends on medical history, current medications, treatment goals, potential contraindications, and the provider’s clinical judgment.
A provider may review:
They are a compounded prescription oral-tablet formulation. A licensed provider determines whether the treatment is medically appropriate for an individual patient.
Tirzepatide acts on GIP and GLP-1 receptor pathways involved in appetite, fullness, food intake, digestion, and blood-sugar regulation. Individual response varies.
Do not assume they are equivalent. Their formulation, administration, absorption, and supporting evidence differ. A provider determines which treatment is appropriate.
No. The provider and pharmacy determine and communicate the formulation, strength, dose, and administration instructions.
There is no guaranteed amount or timeline. Results vary based on treatment response, health history, nutrition, activity, and other factors.
Tirzepatide may affect the absorption and effectiveness of oral hormonal contraceptives. Discuss contraception with the prescribing provider.
Not unless specifically directed by the prescribing provider.
Yes. Standard shipping is included in the displayed program price.
If you are not prescribed the desired medication from our team of medical providers, you will be notified and receive a full refund for all costs incurred. This includes cancellation of any subscription memberships you selected.
Not necessarily. The image is illustrative, and medication arrives in the dispensing pharmacy’s clinical packaging.

Injection
A provider-guided injectable treatment option for eligible patients pursuing medically supervised weight management.

Oral Tablets
A provider-guided oral GLP-1 treatment option for eligible adults pursuing meaningful, sustainable weight-management goals.

Injection
A provider-guided injectable GLP-1 option for eligible patients pursuing medically supervised weight management.
Complete a private online assessment for review by a licensed provider.
No medication is dispensed unless prescribed by a licensed provider.